
Stanley Bruce Cohen MD
Clinical Professor of Medicine, University Tex SW Dallas
Join to view full profile
8144 Walnut Hill LnSuite 800Dallas, TX 75231
Phone+1 214-540-0700
Fax+1 214-540-0701
Dr. Cohen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Rheumatology, 1978 - 1980
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1975 - 1978
University of Alabama School of MedicineClass of 1975
Certifications & Licensure
TX State Medical License 1978 - 2028
AL State Medical License 1976 - 1992
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014, 2016
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
- Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis
Publications & Presentations
PubMed
- Advances in the use of Janus kinase inhibitors.Stanley Cohen, Kevin L Winthrop
Current Opinion in Rheumatology. 2026-05-01 - 9 citationsEULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia.Hanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, John Backlund, Catalin Codreanu
Arthritis & Rheumatology. 2026-03-01 - Denosumab for Osteoporosis Treatment in Rheumatic Diseases: What Do We Know 15 Years Post Approval?Stanley B Cohen, Kenneth G Saag
The Journal of Rheumatology. 2025-09-01
Press Mentions
Reducing Rheumatology Waitlists: Applying Solutions Amid Healthcare System RoadblocksJuly 31st, 2025
Osteoarthritis Drawing ‘Long Overdue’ Excitement, but Disease Modification Still ElusiveJune 6th, 2025
Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene TherapyOctober 28th, 2024
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









